Latest filing published 07 Aug 2026 for DIANTHUS THERAPEUTICS OPCO, INC., €11.8M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Marino Garcia: trading record in brief
Marino Garcia appears in our data through filings on Dianthus Therapeutics, Inc. /DE/ shares, published by SEC (Form 4). Altogether 2 filings, all relating to 7 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 7 August 2026, reports a transaction of €11.8M in Dianthus Therapeutics, Inc. /DE/. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Marino Garcia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 126,000 shares@ US$108.09CommonSEC144:0001950047-26-007793
- 40,000 shares@ US$109.92CommonSEC144:0001950047-26-007814
2 of 2 declarations
